Effect of Non-Soy Legumes on Lipid Profile: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Nutr RevSep 6, 2026
Clinical ResearchCardiologyInternal Medicine (General)

Mohsen Shaygantabar, Ghazaleh Eslamian, Azita Hekmatdoost et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the impact of non-soy legumes on lipid profiles in randomized controlled trials. The analysis included 31 trials and found that non-soy legume consumption significantly reduced total cholesterol (TC) by 5.159 mg/dL and low-density lipoprotein cholesterol (LDL-C) by 3.475 mg/dL. The overall effect on triglycerides was nonsignificant.

Key findings

  • Non-soy legumes significantly reduced total cholesterol by 5.159 mg/dL.
  • LDL-C levels decreased by 3.475 mg/dL with non-soy legume consumption.
  • Significant triglyceride reductions were noted in interventions lasting less than 8 weeks.
  • Participants with BMI <30 kg/m2 experienced a significant reduction in triglycerides.

Why it matters

Understanding the effects of dietary interventions on lipid profiles is crucial for managing cardiovascular disease risk. This study highlights the potential benefits of incorporating non-soy legumes into diets to improve cholesterol levels.

Source

PubMed · PMID 41370093

Published in Nutr Rev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.